Article
Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
International immunopharmacology - 1 Aug 2021
Wang Juncheng, Tian Yuxi, Zhu Gangcai, Li Zhexuan, Wu Zhisheng, Wei Guifang, Zhuang Liming, Li Zhonghua, Chen Xun, Zhang Xin, Zheng Jinyang, Cai Gengming
Abstract excerpt
Tumor cells influencing the microenvironment are essential for restrained immunity in head and neck squamous cell carcinoma (HNSCC). There has been considerable progress in the research on monoclonal antibodies for antigen-specific immunotherapy that overcome immunosuppressive checkpoint receptor/ligand signaling in patients with HNSCC. However, alteration of immunogenicity and formation of neoantigens that lead...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
